Registro:

Referencias:

• Magnus, I.A., Jarrett, A., Prankerd, T.A., Rimington, C., Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia (1961) Lancet, 2, pp. 448-451
• Nakahashi, Y., Taketani, S., Okuda, M., Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase (1990) Biochem Biophys Res Commun, 173, pp. 748-755
• Whitcombe, D.M., Carter, N.P., Albertson, D.G., Assignment of human ferrochelatase gene (FECH) and a locus for protoporphyria on chromosome 18q22 (1991) Genomics, 11, pp. 1152-1154
• Taketani, S., Inazawa, J., Nakahashi, Y., Structure of human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18 (1992) Eur J Biochem, 205, pp. 217-222
• Brenner, D.A., Didier, J.M., Frasier, F., A molecular defect in human protoporphyria (1992) Am J Hum Genet, 50, pp. 1203-1210
• Dailey, H.A., Dailey, T.A., Wu, C.K., Ferrochelatase at the millennium: Structures, mechanisms and [2Fe-2S] clusters (2000) Cell Mol Life Sci, 57, pp. 1909-1926
• Wu, C.K., Dailey, H.A., Rose, J.P., The 2.0 Å structure of human ferrochelatase, the terminal enzyme of heme biosynthesis (2001) Nat Struct Biol, 8, pp. 156-160
• Bonkowsky, H.L., Bloomer, J.R., Ebert, P.S., Mahoney, M.J., Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts (1975) J Clin Invest, 56, pp. 1139-1148
• Bottomley, S.S., Tanaka, M., Everett, M.A., Diminished erythroid ferrochelatase activity in protoporphyria (1975) J Lab Clin Med, 86, pp. 126-131
• Morton, K.O., Schneider, F., Weimer, M.K., Hepatic and bile porphyrins in patients with protoporphyria and liver failure (1988) Gastroenterology, 94, pp. 1488-1492
• Kappas, A., Sassa, S., Gallbraith, R.A., Nordmann, Y., The porphyrias (1989) The Metabolic Basis of Inherited Disease, pp. 1301-1384. , In Scriver C.R. Beaudet A.L. Sly W.S. Valle D. eds. 6th edn. McGraw-Hill, New York
• Anderson, K.E., Sassa, S., Bishop, D.F., Desnick, R.J., The porphyrias (2001) The Metabolic and Molecular Bases of Inherited Disease, pp. 2961-3062. , In Scriver C.R. Beaudet A.L. Sly W.S. Valle D. eds. 8th edn. McGraw Hill, New York
• Lehmann, P., Scharffetter, K., Kind, P., Goerz, G., Erythopoietic protoporphyria: Synopsis of 20 patients (1991) Hautarzt, 42, pp. 570-574
• Doss, M.O., Frank, M., Hepatobiliary implications and complications in protoporphyria, a 20-year study (1989) Clin Biochem, 22, pp. 223-229
• McGuire, B.M., Bonkovsky, H.L., Carithers, Jr.R.L., Liver transplantation for erythropoietic protoporphyria liver disease (2005) Liver Transpl, 11, pp. 1590-1596
• Went, L.N., Klasen, E.C., Genetic aspects of erythropoietic protoporphyria (1984) Ann Hum Genet, 48, pp. 105-117
• Gouya, L., Deybach, J.C., Lamoril, J., Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferroquelatase allele (1996) Am J Hum Genet, 58, pp. 292-299
• Gouya, L., Puy, H., Lamoril, J., Inheritance in erythropoietic protoporphyria: A common Wild-Type ferrochelatase allelic variant with low expression accounts for Clinical Manifestation (1999) Blood, 93, pp. 2105-2110
• Gouya, L., Puy, H., Robreau, A.M., The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH (2002) Nat Genet, 30, pp. 27-28
• Di Pierro, E., Brancaleoni, V., Moriondo, V., Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria (2007) Clin Genet, 71, pp. 84-88
• Lamoril, J., Boulechfar, S., Verneuil, H., Grandchamp, B., Nordmann, Y., Deybach, J.C., Human erythropoietic protoporphyria: Two point mutation in the ferrochelatase gene (1991) Biochem Biophys Res Commun, 181, pp. 594-599
• Sarkany, R.P.E., Alexander, G., Cox, T.M., Recessive inheritance of erythropoietic protoporphyria with liver failure (1994) Lancet, 343, pp. 1394-1396
• Parera, V.E., Minderman, G., Koole, R., Protoporfiria Eritropoyética (2000) Cinco Nuevas Mutaciones en El Gen de la Ferroquelatasa Medicina, 60, p. 842
• Poh-Fitzpatrick, M.B., Wang, X., Anderson, K.E., Bloomer, J.R., Bolwell, B., Lichtin, A.E., Erythropoietic protoporphyria: Altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations (2002) J Am Acad Dermatol, 46, pp. 861-866
• Whatley, S.D., Mason, N.G., Khan, M., Autosomal recessive erythropoietic protoporphyria in the United Kingdom: Prevalence and relationship to liver disease (2004) J Med Genet, 41, pp. e105
• Gouya, L., Martin-Schmitt, C., Robreau, A.M., Contribution of a common single nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria (2006) Am J Hum Genet, 78, pp. 2-14
• Herrero, C., To-Figueras, J., Badenas, C., Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease (2007) Arch Dermatol, 143, pp. 1125-1129
• Holme, S.A., Whatley, S.D., Roberts, A.G., Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance (2009) J Invest Dermatol, 129, pp. 599-605
• Méndez, M., Poblete-Gutiérrez, P., Morán-Jiménez, M.J., A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma (2009) Br J Dermatol, 160, pp. 1330-1334
• Minder, E.I., Schneider-Yin, X., Mamet, R., A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma (2010) J Eur Acad Dermatol Venereol, 24, pp. 1349-1353
• Whatley, S.D., Mason, N.G., Holme, S.A., Molecular epidemiology of erythropoietic protoporphyria in the U.K (2010) Br J Dermatol, 162, pp. 642-646
• Wahlin, S., Floderus, Y., Stål, P., Harper, P., Erythropoietic protoporphyria in Sweden: Demographic, clinical, biochemical and genetic characteristics (2011) J Intern Med, 269, pp. 278-288
• Rufenacht, U.B., Gouya, L., Schneider-Yin, X., Systematic Analysis of Molecular Defects in the Ferrochelatase Gene from Patients with Erythropoietic Protoporphyria (1998) Am J Hum Genet, 62, pp. 1341-1352
• Saruwatari, H., Ueki, Y., Yotsumoto, S., Genetic analysis of the ferrochelatase gene in eight Japonese patients from seven families with erythopoietic protoporphyria (2006) J Dermatol, 33, pp. 603-608
• Aurizi, C., Schneider-Yin, X., Sorge, F., Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria (2007) Mol Genet Metab, 90, pp. 402-407
• Whatley, S.D., Mason, N.G., Holme, S.A., Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria (2007) J Invest Dermatol, 127, pp. 2790-2794
• Zhou, S.N., Xiao, S.X., Peng, Z.H., A novel mutation of the FECH gene in a Chinese family with erythropoietic protoporphyria (2007) J Dermatol Sci, 48, pp. 145-147
• Parker, M., Corrigall, A.V., Hift, R.J., Meissner, P.N., Molecular characterization of Erythropoietic protoporphyria in South Africa (2008) Br J Dermatol, 159, pp. 182-191
• Di Pierro, E., Brancaleoni, V., Besana, V., A 10376 bp deletion of FECH gene responsible for erythropoietic protoporphyria (2008) Blood Cells Mol Dis, 40, pp. 233-236
• Brancaleoni, V., Di Pierro, E., Besana, V., Gene Symbol: FECH. Disease: Porphyria, erythropoietic (2008) Hum Genet, 124, pp. 293-324
• Schneider-Yin, X., Mamet, R., Minder, E.I., Schoenfeld, N., Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family (2008) J Inherit Metab Dis, 31, pp. S363-S367
• Parera, V.E., Koole, R.H., Minderman, G., Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria (2009) Mol Med, 15, pp. 425-431
• Lau, K.C., Lam, C.W., Fong, B., DNA-based diagnosis of erythropoietic protoporphyria in two families and the frequency of a low-expression FECH allele in a Chinese population (2009) Clin Chim Acta, 400, pp. 132-134
• Li, C., Di Pierro, E., Brancaleoni, V., A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria (2009) Clin Chem Lab Med, 47, pp. 44-46
• Ma, J., Xiao, S., An, J., A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria (2010) J Eur Acad Dermatol Venereol, 6, pp. 726-729
• Human Gene Mutation Database, , http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FECH, The Institute of Medical genetics in Cardiff. Available at Accessed February 18, 2012
• Kitts, A., Sherry, S., NCBI Handbook the Single Nucleotide Polymorphism Database (DbSNP) of Nucleotide Sequence Variation, , http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?chooseRs=all&go= Go&locusId=2235, Available at Accessed February 18, 2012
• Caceres, J.F., Kornblihtt, A.R., Alternative splicing: Multiple control mechanisms and involvement in human disease (2002) Trends Genet, 18, pp. 186-193
• Nakahashi, Y., Fujita, H., Taketani, S., The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria (1992) Proc Natl Acad Sci USA, 89, pp. 281-285
• Di Pierro, E., Cappellini, M.D., Mazzucchelli, R., A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria (2005) Exp Hematol, 33, pp. 584-591
• Magness, S.T., Tugores, A., Brenner, D.A., Analysis of ferrochelatase expression during hematopoietic development of embryonic stem cells (2000) Blood, 95, pp. 3568-3577
• Batlle, A.M.C., El Laboratorio de las Porfirias (1997) Acta Bioquímica Clínica Latinoamericana, pp. 141-175. , Porfirias y Porfirinas , eds. Aspectos clínicos, bioquímicos y biología molecular. Actualizaciones Médico-Bioquímicas. Federaciõn Bioquímica de la Provincia de Buenos Aires, Argentina
• Wiman, A., Floderus, Y., Harper, P., Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria (2003) J Hum Genet, 48, pp. 70-76
• Henriksson, M., Timonen, K., Mustajoki, P., Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients (1996) J Invest Dermatol, 106, pp. 346-350
• Gouya, L., Schneider-Yin, X., Rüfenacht, U., Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria (1998) J Invest Dermatol, 111, pp. 406-409
• Kong, X.F., Ye, J., Gao, D.Y., Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria (2008) J Hepatol, 48, pp. 375-379
• Hartmann, L., Theiss, S., Niederacher, D., Schaal, H., Diagnostics of pathogenic splicing mutations: Does bioinformatics cover all bases? (2008) Front Biosci, 13, pp. 3252-3272
• Lecha, M., Puy, H., Deybach, J.C., Erythropoietic protoporphyria (2009) Orphanet J Rare Dis, 4, p. 19
• Whatley, S.D., Ducamp, S., Gouya, L., C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload (2008) Am J Hum Genet, 83, pp. 408-414
• Imoto, S., Tanizawa, Y., Sato, Y., A novel mutation in the ferrochelatase gene associated with erytropoietic protoporphyria (1996) Br J Haematol, 94, pp. 191-197
• Schneider-Yin, X., Schafer, B.W., Tonz, O., Minder, E.I., Human ferrochelatase: A novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing (1995) Hum Genet, 95, pp. 391-396
• Frank, J., Nelson, J., Wang, X., Erythropoietic protoporphyria: Identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies (1999) J Investig Med, 47, pp. 278-284
• Di Pierro, E., Moriondo, V., Cappellini, M.D., Gene Symbol: FECH. Disease: Porphyria, erythropoietic (2004) Hum Genet, 114, p. 221

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------